DANAHER CORP.
Market Reports 📊 123 Reports
26. Bioprocess Optimization and Digital Bio-manufacturing: Global Markets
BCC Research Market Analyst says global market for bioprocess optimization and digital biomanufacturing is expected to grow from $24.3 billion in 2024 and is projected to reach $39.6 billion by the en
27. Microscopy: The Global Market
BCC Research Report: Dive into microscopy market estimates, data has been provided for 2021, 2022, and 2023 as the base year, 2024, and a forecast for 2029.
28. Medical Devices Industry: Competitive Landscape
BCC Research Market Analyst says global market for medical devices is estimated to increase from 810.4 billion in 2024 to reach $1.3 trillion by 2029, at a CAGR of 9.8%.
29. Single-use Technologies for Biopharmaceuticals: Global Markets
BCC Research Market Analyst says global market for single-use technologies for biopharmaceuticals is expected to grow from $6.5 billion in 2024 and is projected to reach $11.2 billion by the end of 20
30. CRISPR Technology: Global Markets
BCC Research Market Analyst says global market for CRISPR technology was valued at $3.4 billion in 2023 & is expected to grow from $3.8 billion in 2024 to $7.5 billion by the end of 2029.
31. Medical Devices: Technologies and Global Markets
BCC Research Market Analyst says global market for medical devices reached $739.6 billion in 2023 & expected to grow from $810.4 billion in 2024 to $1.3 trillion by the end of 2029 at a CAGR of 9.8%.
32. Point-of-Care Diagnostics: Technologies and Global Markets
BCC Research Market Analyst says global market for point-of-care diagnostics was valued at $36.9 billion in 2023 & expected to grow from $40.6 billion in 2024 to $65.9 billion by the end of 2029 at a
33. European Life Science Tools and Reagents Market
BCC Research Market Analyst says European market for life science tools and reagents and COVID-19 diagnostics products was valued at $14.7 billion in 2023.
34. Drug Discovery Technologies
BCC Research Market Analyst says global market for drug discovery technologies is expected to grow from $111.9 billion in 2024 and is projected to reach $197.0 billion by the end of 2029.
35. Global Live Cell Imaging Market
BCC Research Market Analyst says global market for live cell imaging is expected to grow from $2.9 billion in 2024 and is projected to reach $4.3 billion by the end of 2029, at a CAGR of 8.4%.
36. Global Single-cell Technologies Market
BCC Research Market Analyst says global market for single-cell technologies is estimated to increase from $3.6 billion in 2023 to reach $9.2 billion by 2029, at a CAGR of 17.1%
37. Global Automated and Closed Cell Therapy Market
BCC Research Market Analyst says global market for automated and closed cell therapy is expected to grow from $1.8 billion in 2024 and is projected to reach $5.3 billion by the end of 2029 at a CAGR o
38. Cell Therapy Biomanufacturing: Global Markets
BCC Research Market Analyst says global market for cell therapy biomanufacturing is expected to grow from $9.7 billion in 2024 and is projected to reach $16.7 billion by the end of 2029 at a CAGR of 1
39. In Vitro Diagnostics (IVD) Quality Controls: Global Market
BCC Research Market Report provides an overview of In Vitro Diagnostics Quality Controls Market report is being produced due to ongoing demand for diagnosis of diseases and evolution of different infe
40. Drugs and Diagnostics for Hematological Disorders: Global Markets
BCC Research Market Analyst says global market for global market for drugs and diagnostics for hematological disorders is expected to grow from $131.2 billion in 2024 and is projected to reach $189.3
41. Life Science Tools and Reagents: Global Markets
BCC Research Market Analyst says global market for life science tools and reagents, including COVID-19 diagnostics was valued at $59.4 billion in 2023 and expected to grow from $53.2 billion in 2024 t
42. Metabolomics: Technologies and Global Markets
BCC Research Market Analyst says global market for metabolomics technologies is expected to grow from $16.4 billion in 2024 and is projected to reach $30.2 billion by the end of 2029.
43. Polymerase Chain Reaction (PCR) for Point-of-Care (POC) Diagnostics
BCC Research Market Analyst says global market for polymerase chain reaction for point-of-care diagnostics is expected to grow from $1.6 billion in 2024 to $2.1 billion by the end of 2029 at a CAGR of
44. Gene Synthesis: Technologies and Global Markets
BCC Research Market Analyst says global market for Gene Synthesis is estimated to increase from $2.0 billion in 2023 to reach $4.1 billion by 2028 at a CAGR of 15.8%.
45. Flow Cytometry: Products, Technologies and Global Markets
BCC Research Market Analyst says global market for flow cytometry products is expected to grow from $5.2 billion in 2023 to $8.3 billion by the end of 2029, at a CAGR of 8.2% from 2024 to 2029.
46. Companion Diagnostics: Technologies and Markets
BCC Research Market Report provides an overview of Companion Diagnostics Market analysis of the current trends, along with industry growth drivers, opportunities, restraints, and challenges.
47. Viral Vector and Plasmid DNA: Technologies and Global Markets
BCC Research Market Analyst says global market for viral vector and plasmid DNA technologies is expected to grow from $2.9 billion in 2023 to $7.1 billion by the end of 2028 at a CAGR of 19.7%.
48. 3D Cell Cultures: Technologies and Global Markets
BCC Research Market Analyst says global market for 3D cell culture is estimated to increase from $4.6 billion in 2023 to reach $14.8 billion by 2028 at a CAGR of 26.5% from 2023 through 2028.
49. Prevention and Treatment of Prostate Cancer: Technologies and Global Markets
BCC Research Market Analyst says global market for prostate cancer care is expected to grow from $37.9 billion in 2023 to $56.4 billion by the end of 2028, at a CAGR of 8.3% from 2023 through 2028.
50. Next-generation Sequencing: Emerging Clinical Applications and Global Markets
Discover BCC Research's report on Next-generation Sequencing Market is steadily being integrated into clinical laboratory analysis, testing, and disease diagnostics in healthcare sectors globally.
